1. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items 
Antonio Valero, MD, PhD, Montse Ferrer, MD, PhD, Joaquín Sastre, MD, PhD, Ana M. Navarro, MD, PhD, Laura Monclús, MD, Enrique Martí-Guadaño, MD, PhD, Michael Herdman, MSc, Ignacio Dávila, MD, PhD, Alfonso del Cuvillo, MD, PhD, Carlos Colás, MD, PhD, Eva Baró, BSc, Ignacio Antépara, MD, PhD, Jordi Alonso, MD, PhD, Joaquim Mullol, MD, PhD 
Journal of Allergy and Clinical Immunology 
Volume 120, Issue 2, Pages (August 2007)
DOI: /j.jaci
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Distribution of patients with moderate/severe allergic rhinitis (N = 141) on symptoms (TSS4) and HRQL (RQLQ global score, SF-12 MCS and PCS).
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Fig 2
Distribution of patients when defined by the number of affected ARIA items in severe (4 impaired items) and moderate (those with 1, 2, or 3 impaired items). Mean ± SD and P value of t test comparing moderate and severe groups were as follows: for TSS4, symptom score 7.3 ± 2.2 vs 8.7 ± 2.0 (P < .0004); for RQLQ, global score 2.4 ± 1.0 vs 3.5 ± 0.9 (P < .0001); for SF-12 PCS, score 49.8 ± 7.9 vs 40.5 ± 9.3 (P < .0001); and for SF-12 MCS, score 47.9 ± 9.9 vs 45.6 ± 11.0 (NS).
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci )
Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions